Objective Cancer stem cells (CSCs) represent the root of many solid cancers including pancreatic ductal adenocarcinoma, are highly chemoresistant and represent the cellular source for disease relapse. However the mechanisms involved in these processes still need to be fully elucidated. Understanding the mechanisms implicated in chemoresistance and metastasis of pancreatic cancer is critical to improving patient outcomes. Design Micro-RNA (miRNA) expression analyses were performed to identify functionally defining epigenetic signatures in pancreatic CSC-enriched sphere-derived cells and gemcitabine-resistant pancreatic CSCs. Results We found the miR-17-92 cluster to be downregulated in chemoresistant CSCs versus non-CSCs and demonstrate its ...
Pancreatic ductal adenocarcinoma is currently one of the deadliest cancers with low overall survival...
Background: MicroRNA-34a (miR-34a) is a transcriptional target of p53 and is down-regulated in pancr...
MicroRNAs (miRNAs) encoded by the miR-17-92 cluster and its paralogs are known to act as oncogenes. ...
Objective Cancer stem cells (CSCs) represent the root of many solid cancers including pancreatic duc...
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy characterized by resistance to curren...
PMCID: PMC5295626.-- et al.Pancreatic ductal adenocarcinoma (PDAC) and other carcinomas are hierarch...
Pancreatic ductal adenocarcinoma (PDAC) and other carcinomas are hierarchically organized, with canc...
Abstract The miR-17-92 microRNA cluster is often activated in cancer cells, but the identity of its ...
The miR-17-92 microRNA cluster is often activated in cancer cells, but the identity of its targets r...
Pancreatic ductal adenocarcinoma (PDAC) and other carcinomas are hierarchically organized, with canc...
Pancreatic ductal adenocarcinoma (PDAC) is an extremely severe disease where the mortality and incid...
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer ...
Background: No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic...
The synergism between c-MYC and miR-17-19b, a truncated version of the miR-17-92 cluster, is well-do...
Pancreatic ductal adenocarcinoma is currently one of the deadliest cancers with low overall survival...
Background: MicroRNA-34a (miR-34a) is a transcriptional target of p53 and is down-regulated in pancr...
MicroRNAs (miRNAs) encoded by the miR-17-92 cluster and its paralogs are known to act as oncogenes. ...
Objective Cancer stem cells (CSCs) represent the root of many solid cancers including pancreatic duc...
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy characterized by resistance to curren...
PMCID: PMC5295626.-- et al.Pancreatic ductal adenocarcinoma (PDAC) and other carcinomas are hierarch...
Pancreatic ductal adenocarcinoma (PDAC) and other carcinomas are hierarchically organized, with canc...
Abstract The miR-17-92 microRNA cluster is often activated in cancer cells, but the identity of its ...
The miR-17-92 microRNA cluster is often activated in cancer cells, but the identity of its targets r...
Pancreatic ductal adenocarcinoma (PDAC) and other carcinomas are hierarchically organized, with canc...
Pancreatic ductal adenocarcinoma (PDAC) is an extremely severe disease where the mortality and incid...
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer ...
Background: No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic...
The synergism between c-MYC and miR-17-19b, a truncated version of the miR-17-92 cluster, is well-do...
Pancreatic ductal adenocarcinoma is currently one of the deadliest cancers with low overall survival...
Background: MicroRNA-34a (miR-34a) is a transcriptional target of p53 and is down-regulated in pancr...
MicroRNAs (miRNAs) encoded by the miR-17-92 cluster and its paralogs are known to act as oncogenes. ...